Pulmonary MRI of Ex-preterm Children With and Without BPD To Understand Risk of Emphysematous Changes
PICTURE
Pulmonary Magnetic Resonance Imaging of Ex-preterm Children With and Without Bronchopulmonary Dysplasia To Understand Risk of Emphysematous Changes (PICTURE)
1 other identifier
observational
45
1 country
4
Brief Summary
Health Issue: Bronchopulmonary dysplasia (BPD), a chronic lung disease, is the most common complication of being born premature. Damage to the still developing lung stops the normal formation of the alveoli. Young adults with a history of BPD have lower lung function, early heart disease, and increased risk of death, compared to those without BPD. Recently, it has been reported that they may also develop a type of lung disease typically seen in older adults with a longstanding history of smoking. The severity of lung disease is usually measured using pulmonary function tests (PFT), but these tests may be normal, even in the presence of important changes in the fine structure of the lung. Such structural changes may be early markers of future lung disease and can be detected using lung magnetic resonance imaging (MRI). Unlike other ways of imaging the lungs, MRI does not expose people to harmful X-rays. To date, no studies have been done to examine the fine structure of the lung of school-aged children who had a history of BPD, to determine whether there are signs of lung disease that might not otherwise be obvious. This is important because once armed with this information, preventive measures can be taken to avoid worsening of lung disease. Objective: 1) In 7-9 year-old children born extremely premature, lung MRI will be compared between those with and without BPD. The Investigators expect to observe more severe structural lung abnormalities in children with BPD, compared to those without BPD; 2) The Investigators will test to see if children with more severe MRI abnormalities also have worse lung function, and/or more symptoms of breathing problems. The Investigators expect to observe more PFT abnormalities in children with BPD than in those without and that these will match up with lung fine structure abnormalities identified on MRI. How will work be undertaken? Children 7-9 years old who were born extremely prematurely will be recruited to participate in this study. Participants will be identified from Neonatal Follow-up clinics they attended. The Investigators will enroll 20 children with BPD and 20 without BPD. Participants will have lung MR images taken, during which they need to lie still for a few minutes. PFT will also be performed, during which they will blow into a machine. Parents will be asked to complete questionnaires about breathing problems, their living conditions (environment) and any doctor visits or hospital stays. Medical charts will be reviewed for information about their birth. Unique/Innovative Aspects: This will be the first study using MRI as an innovative way to visualize and measure fine structure of the lung in children born prematurely with and without BPD. These findings may be early markers of lung disease, which would identify children who have, or are at risk of developing lung disease later in life, for whom the Investigators may be able to offer treatments now and/or prevent worsening of lung disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2018
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 18, 2016
CompletedFirst Posted
Study publicly available on registry
October 3, 2016
CompletedStudy Start
First participant enrolled
January 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 18, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 18, 2019
CompletedJuly 31, 2020
July 1, 2020
1.7 years
August 18, 2016
July 29, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary Outcome: MRI-derived Pulmonary Microstructure measurements
Images will be acquired in 10-15 seconds in all subjects using a 2D radial ultra-short echo time pulse sequence, to quantify signal intensity as a surrogate of parenchymal tissue density. Subjects will be asked to breath normally and then inhale a fixed volume of air from functional residual capacity (the volume of which is calibrated to 50% of inspiratory capacity) and hold their breath while images are acquired, as previously described. The pulse sequence for imaging will be developed as previously described and validated for the different MR scanner platforms at the three participating sites, through the Imaging platform of the Canadian Respiratory Research Network. All image volumes will be scaled to functional residual capacity plus 50% of inspiratory capacity and will be acquired in breath-hold at that inspiratory volume. The CRRN Imaging platform will also provide test objects for calibration of 1H MRI signal intensity to ensure
Assessed at one time point at Baseline
Secondary Outcomes (16)
Height
Assessed at one time point at Baseline
Weight
Assessed at one time point at Baseline
Airflow limitations
Assessed at one time point at Baseline
Airflow limitations
Assessed at one time point at Baseline
Airflow limitations
Assessed at one time point at Baseline
- +11 more secondary outcomes
Study Arms (2)
With BPD
No intervention will be administered. After informed consent is obtained, children will undergo ultra-short echo time pulmonary MRI, followed by PFT and completion of questionnaires.
Without BPD
No intervention will be administered. After informed consent is obtained, children will undergo ultra-short echo time pulmonary MRI, followed by PFT and completion of questionnaires.
Eligibility Criteria
Children born pre-term at less than 28 weeks' gestation, currently aged 7-9 years, with and without BPD will be included. BPD will be defined as need for oxygen at 36 weeks' postmenstrual age,2 which includes those with moderate-severe disease.47 Children 7-9 years of age were selected in order to include the youngest age at which pulmonary function, including lung volumes and single breath pulmonary diffusing capacity for carbon monoxide, can routinely be reliably measured using methods that require subject cooperation.
You may not qualify if:
- Children with known interstitial lung disease, congenital lung anomalies, cystic fibrosis, ciliary dysfunction, immunodeficiency, neuromuscular disease or structural heart disease, which may have associated PFT and/or MRI findings;
- Genetic syndromes which may have other associated structural lung anomalies;
- Any contraindications for MRI;
- Severe neurosensory deficits which would prevent test completion;
- Viral or bacterial respiratory infection within 6 weeks.50
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Children's Hospital of Eastern Ontario
Ottawa, Ontario, K1H 8L1, Canada
The Children"s Hospital of Eastern Ontario
Ottawa, Ontario, K1H 8L1, Canada
Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
CHU-Sainte Justine
Montreal, Quebec, H3T 1C5, Canada
Related Publications (1)
Katz SL, Parraga G, Luu TM, Santyr G, Abdeen N, Deschenes S, Tse SM, Couch MJ, Barrowman N, Hayawi L, Momoli F, Blinder H, Thebaud B, Nuyt AM, Ben Fadel N, Moraes TJ. Pulmonary Magnetic Resonance Imaging of Ex-Preterm Children with and without Bronchopulmonary Dysplasia. Ann Am Thorac Soc. 2022 Jul;19(7):1149-1157. doi: 10.1513/AnnalsATS.202106-691OC.
PMID: 35030070DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sherri Katz
Children's Hospital of Eastern Ontario
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Pediatric Respirologist
Study Record Dates
First Submitted
August 18, 2016
First Posted
October 3, 2016
Study Start
January 5, 2018
Primary Completion
September 18, 2019
Study Completion
September 18, 2019
Last Updated
July 31, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share